Page last updated: 2024-08-21

pyrazines and k 7174

pyrazines has been researched along with k 7174 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akutsu, M; Furukawa, Y; Izumi, T; Kano, Y; Kikuchi, J; Koyama, D; Nobuyoshi, M; Wada, T; Yamada, S	1

Trials

1 trial(s) available for pyrazines and k 7174

Article	Year
The novel orally active proteasome inhibitor K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases. The Journal of biological chemistry, 2013, Aug-30, Volume: 288, Issue:35 Topics: Administration, Oral; Animals; Anisoles; Antineoplastic Agents; Azepines; Boronic Acids; Bortezomib; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Pyrazines	2013

Article

Year

The novel orally active proteasome inhibitor K-7174 exerts anti-myeloma activity in vitro and in vivo by down-regulating the expression of class I histone deacetylases.

The Journal of biological chemistry, 2013, Aug-30, Volume: 288, Issue:35

Topics: Administration, Oral; Animals; Anisoles; Antineoplastic Agents; Azepines; Boronic Acids; Bortezomib; Cell Line, Tumor; Down-Regulation; Drug Resistance, Neoplasm; Female; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Pyrazines

2013